Quest Diagnostics
DGX
#1167
Rank
$15.43 B
Marketcap
$138.96
Share price
0.55%
Change (1 day)
0.67%
Change (1 year)
Quest Diagnostics is an American clinical laboratory company offering access to diagnostic testing services for cancer, cardiovascular disease, infectious disease, neurological disorders and employment and court ordered drug testing.

Quest Diagnostics (DGX) - Total liabilities

Total liabilities on the balance sheet as of March 2024 : $7.40 B

According to Quest Diagnostics 's latest financial reports the company's total liabilities are $7.40 B. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Quest Diagnostics - Total liabilities on balance sheet (from 2001 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31$7.60 B11.33%
2022-12-31$6.83 B-3.11%
2021-12-31$7.04 B-1.21%
2020-12-31$7.13 B0.78%
2019-12-31$7.08 B25.11%
2018-12-31$5.65 B3.49%
2017-12-31$5.46 B1.96%
2016-12-31$5.36 B3.55%
2015-12-31$5.17 B-6.3%
2014-12-31$5.52 B11.1%
2013-12-31$4.97 B-2.41%
2012-12-31$5.09 B-8.94%
2011-12-31$5.59 B25.15%
2010-12-31$4.47 B-1.73%
2009-12-31$4.55 B-5.14%
2008-12-31$4.79 B-8.44%
2007-12-31$5.24 B98.37%
2006-12-31$2.64 B3.9%
2005-12-31$2.54 B32.79%
2004-12-31$1.91 B0.44%
2003-12-31$1.90 B22.59%
2002-12-31$1.55 B-2.46%
2001-12-31$1.59 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
$8.55 B 15.50%๐Ÿ‡บ๐Ÿ‡ธ USA
$4.87 M-99.93%๐Ÿ‡บ๐Ÿ‡ธ USA
$0.71 B-90.32%๐Ÿ‡บ๐Ÿ‡ธ USA
$2.20 B-70.22%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
$28.3 M-99.62%๐Ÿ‡บ๐Ÿ‡ธ USA